Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
Glasses for Adolescent Delayed Sleep-Wake Phase Disorder

The purpose of this study is to determine if evening amber glasses combined with stable wake times will show an increase in total sleep time (TST) and an advance in sleep onset times (shift earlier) compared to the control group.

  • 0 views
  • 16 Feb, 2024
  • 1 location
An Open Label Study of FT218 in Subjects With Narcolepsy

An Open Label Study to Evaluate Long-Term Safety and Tolerability of a Once Nightly Formulation of Sodium Oxybate for Extended-Release Oral Suspension (FT218) and the ability to switch from twice-nightly immediate release sodium oxybate to once-nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Subjects with Narcolepsy

somnolence
excessive daytime sleepiness
sodium oxybate
narcolepsy
sleepiness
  • 0 views
  • 05 Aug, 2020
Impact of Sleep Deprivation and Caffeine in Medical Professionals

Previous work from members of our team investigated diagnostic reasoning in medical professionals and discovered that brain activation in executive processing areas was modulated by self-reported sleepiness and burnout and level of expertise (Durning, Costanzo, et al., 2013; Durning et al., 2014, 2015). The current study aims to expand upon …

sleepiness
caffeine
  • 0 views
  • 16 Feb, 2024
  • 1 location
Daytime Sleepiness in Patients With the Assessment of a Sleep-related Respiratory Disorder

It is not yet known whether an analysis of daytime sleepiness over the course of the day can predict the diagnosis or severity of sleep apnea. The goal of the study is to examine whether a psychometric determination of daytime sleepiness can adequately and practicably record daytime sleepiness in patients …

  • 0 views
  • 05 Aug, 2020
Clinical Features Associated With Restless Legs Syndrome.

RLS can lead to a sleep deprivation, increased falling risk, daytime sleepiness, depression and decreased quality of life. Dopamine agonists, alpha-2-delta ligands and opiates are key medications for RLS. The natural course of RLS is very heterogeneous with a risk of increasing the severity of symptoms over the years despite …

dopamine agonists
sleepiness
restless legs syndrome
neurological disorder
depression
  • 0 views
  • 15 Sep, 2021
  • 1 location
Neurodegenerative Diseases Registry

With the increase in life expectancy of our population due to advancement of medical diagnosis and treatments, the incidence of age dependent neurodegenerative diseases increased, including Alzheimer's disease (AD), parkinsonian syndromes (PS), small vessel disease (SVD) and motor neuron disease (MND). In spite of the progress of knowing the pathogenesis …

neurodegenerative diseases
motor neuron disease
neurodegenerative disorders
neurodegenerative disorder
parkinsonism
  • 0 views
  • 05 Aug, 2020